Counterpoint Mutual Funds LLC Acquires New Position in STERIS plc (NYSE:STE)

Counterpoint Mutual Funds LLC purchased a new position in STERIS plc (NYSE:STE - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 1,339 shares of the medical equipment provider's stock, valued at approximately $275,000.

Several other large investors have also recently modified their holdings of the stock. Cibc World Markets Corp raised its position in shares of STERIS by 16.3% in the 4th quarter. Cibc World Markets Corp now owns 15,569 shares of the medical equipment provider's stock worth $3,200,000 after purchasing an additional 2,181 shares during the last quarter. Avalon Trust Co purchased a new position in shares of STERIS in the 4th quarter worth about $30,000. Hilton Capital Management LLC raised its position in shares of STERIS by 4.5% in the 4th quarter. Hilton Capital Management LLC now owns 6,887 shares of the medical equipment provider's stock worth $1,416,000 after purchasing an additional 297 shares during the last quarter. LBP AM SA raised its position in STERIS by 151.3% in the 4th quarter. LBP AM SA now owns 26,519 shares of the medical equipment provider's stock worth $5,451,000 after buying an additional 15,965 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in STERIS by 41.9% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,117 shares of the medical equipment provider's stock worth $230,000 after buying an additional 330 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company's stock.

Analyst Ratings Changes

A number of brokerages have weighed in on STE. Piper Sandler boosted their target price on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. JMP Securities reissued a "market outperform" rating and issued a $265.00 target price on shares of STERIS in a research report on Thursday, February 6th. Finally, Stephens reissued an "overweight" rating and issued a $240.00 target price on shares of STERIS in a research report on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $258.75.

Remove Ads

STERIS Stock Performance

Shares of STERIS stock traded down $5.13 during trading hours on Friday, reaching $220.34. 1,348,122 shares of the stock traded hands, compared to its average volume of 504,894. The company has a 50 day moving average price of $221.02 and a 200 day moving average price of $222.12. The firm has a market capitalization of $21.65 billion, a price-to-earnings ratio of 46.78 and a beta of 0.92. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, equities research analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were paid a dividend of $0.57 per share. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.03%. STERIS's dividend payout ratio is currently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.